IBDEI0FN ; ; 03-MAY-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4)
;;=^IBE(358.4,
;;^UTILITY(U,$J,358.4,0)
;;=IMP/EXP SELECTION GROUP^358.4I^1536^1504
;;^UTILITY(U,$J,358.4,1,0)
;;=NEW PATIENT^2^1
;;^UTILITY(U,$J,358.4,2,0)
;;=ESTABLISHED PATIENT^1^1
;;^UTILITY(U,$J,358.4,3,0)
;;=CONSULTATIONS^3^1
;;^UTILITY(U,$J,358.4,4,0)
;;=ALLERGY DIAGNOSES^1^2
;;^UTILITY(U,$J,358.4,5,0)
;;=IMMUNODEFICIENCY^2^2
;;^UTILITY(U,$J,358.4,6,0)
;;=OTHER^3^2
;;^UTILITY(U,$J,358.4,7,0)
;;=IMMUNIZATION^4^3
;;^UTILITY(U,$J,358.4,8,0)
;;=SKIN TEST^9^3
;;^UTILITY(U,$J,358.4,9,0)
;;=ALLERGENIC EXTRACT^1^3
;;^UTILITY(U,$J,358.4,10,0)
;;=PATCH TESTS^8^3
;;^UTILITY(U,$J,358.4,11,0)
;;=ALLERGY INJECTION/EXTRACT^2^3
;;^UTILITY(U,$J,358.4,12,0)
;;=LABORATORY^6^3
;;^UTILITY(U,$J,358.4,13,0)
;;=INFUSIONS^5^3
;;^UTILITY(U,$J,358.4,14,0)
;;=OTHER^7^3
;;^UTILITY(U,$J,358.4,15,0)
;;=EDUCATION/TRAINING^1^4
;;^UTILITY(U,$J,358.4,16,0)
;;=FAMILY TRAINING-GROUP^2^4
;;^UTILITY(U,$J,358.4,17,0)
;;=PROCEDURE CODES-GROUP^3^4
;;^UTILITY(U,$J,358.4,18,0)
;;=RECREATION THERAPY DX^1^5
;;^UTILITY(U,$J,358.4,19,0)
;;=SDOH^2^5
;;^UTILITY(U,$J,358.4,20,0)
;;=1-1 THERAPEUTIC PROCEDURES^1^6
;;^UTILITY(U,$J,358.4,21,0)
;;=EDUCATION/TRAINING^3^6
;;^UTILITY(U,$J,358.4,22,0)
;;=TEAM CONFERENCE^6^6
;;^UTILITY(U,$J,358.4,23,0)
;;=ASSESSMENT^2^6
;;^UTILITY(U,$J,358.4,24,0)
;;=FAMILY TRAINING^4^6
;;^UTILITY(U,$J,358.4,25,0)
;;=SPECIALTY PROCEDURES-INDIVIDUAL^5^6
;;^UTILITY(U,$J,358.4,26,0)
;;=RECREATION THERAPY DX^1^7
;;^UTILITY(U,$J,358.4,27,0)
;;=SDOH^2^7
;;^UTILITY(U,$J,358.4,28,0)
;;=SPECIAL SERVICES^10^8
;;^UTILITY(U,$J,358.4,29,0)
;;=CHEMO NURSE PROCEDURES^2^8
;;^UTILITY(U,$J,358.4,30,0)
;;=INFUSION DRUGS^7^8
;;^UTILITY(U,$J,358.4,31,0)
;;=BLOOD PRODUCTS^1^8
;;^UTILITY(U,$J,358.4,32,0)
;;=DIAGNOSTIC PROCEDURES^3^8
;;^UTILITY(U,$J,358.4,33,0)
;;=OTHER DRUGS^8^8
;;^UTILITY(U,$J,358.4,34,0)
;;=IMMUNIZATION ADMINISTRATION^5^8
;;^UTILITY(U,$J,358.4,35,0)
;;=IMMUNIZATIONS^6^8
;;^UTILITY(U,$J,358.4,36,0)
;;=PROLONGED SVC-MD/NP/PA^9^8
;;^UTILITY(U,$J,358.4,37,0)
;;=EDUCATION/TRAINING^4^8
;;^UTILITY(U,$J,358.4,38,0)
;;=NEW PATIENT^2^9
;;^UTILITY(U,$J,358.4,39,0)
;;=ESTABLISHED PATIENT^1^9
;;^UTILITY(U,$J,358.4,40,0)
;;=CONSULTATIONS^3^9
;;^UTILITY(U,$J,358.4,41,0)
;;=COMPLEX CHRONIC CARE^4^9
;;^UTILITY(U,$J,358.4,42,0)
;;=ANEMIA^1^10
;;^UTILITY(U,$J,358.4,43,0)
;;=ARTIFICIAL OPENING STATUS^2^10
;;^UTILITY(U,$J,358.4,44,0)
;;=BREASTS and GYN NEOPLASMS^3^10
;;^UTILITY(U,$J,358.4,45,0)
;;=COAGULATION DISORDERS^4^10
;;^UTILITY(U,$J,358.4,46,0)
;;=COUNSELING AND SCREENING^5^10
;;^UTILITY(U,$J,358.4,47,0)
;;=GENITOURINARY NEOPLASMS^6^10
;;^UTILITY(U,$J,358.4,48,0)
;;=GI CANCER^7^10
;;^UTILITY(U,$J,358.4,49,0)
;;=HEAD NECK AND LUNGS NEOPLASMS^8^10
;;^UTILITY(U,$J,358.4,50,0)
;;=HEMOGLOBINOPATHIES^9^10
;;^UTILITY(U,$J,358.4,51,0)
;;=LYMPHOID NEOPLASMS^10^10
;;^UTILITY(U,$J,358.4,52,0)
;;=METASTATIC SITES^13^10
;;^UTILITY(U,$J,358.4,53,0)
;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^10
;;^UTILITY(U,$J,358.4,54,0)
;;=MYELOID NEOPLASMS AND DISORDERS^14^10
;;^UTILITY(U,$J,358.4,55,0)
;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^10
;;^UTILITY(U,$J,358.4,56,0)
;;=NEOPLASM OF UNSPECIFIED NATURE^16^10
;;^UTILITY(U,$J,358.4,57,0)
;;=PERSONAL HISTORY^19^10
;;^UTILITY(U,$J,358.4,58,0)
;;=MALNUTRITION^12^10
;;^UTILITY(U,$J,358.4,59,0)
;;=OTHER^18^10
;;^UTILITY(U,$J,358.4,60,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^20^10
;;^UTILITY(U,$J,358.4,61,0)
;;=ESTABLISHED PATIENT^1^11
;;^UTILITY(U,$J,358.4,62,0)
;;=CARE PLAN OVERSIGHT^1^12
;;^UTILITY(U,$J,358.4,63,0)
;;=OTHER SERVICES^4^12
;;^UTILITY(U,$J,358.4,64,0)
;;=CASE MANAGEMENT^2^12
;;^UTILITY(U,$J,358.4,65,0)
;;=EDUCATION^3^12
;;^UTILITY(U,$J,358.4,66,0)
;;=CARDIOVASCULAR DISORDERS^1^13
;;^UTILITY(U,$J,358.4,67,0)
;;=CONDITIONS AFFECTING HEALTH CARE STATUS^2^13
;;^UTILITY(U,$J,358.4,68,0)
;;=DIABETES^4^13
;;^UTILITY(U,$J,358.4,69,0)
;;=EYE & EAR DISORDERS^4^13
;;^UTILITY(U,$J,358.4,70,0)
;;=MENTAL HEALTH^5^13
;;^UTILITY(U,$J,358.4,71,0)
;;=NEOPLASMS^6^13
;;^UTILITY(U,$J,358.4,72,0)
;;=NEUROLOGICAL CONDITIONS^7^13
;;^UTILITY(U,$J,358.4,73,0)
;;=OTHER CONDITIONS^8^13
;;^UTILITY(U,$J,358.4,74,0)
;;=RESPIRATORY DISORDERS^9^13
;;^UTILITY(U,$J,358.4,75,0)
;;=DEMENTIA^3^13
;;^UTILITY(U,$J,358.4,76,0)
;;=ACOUSTIC NERVE INJURIES^1^14
;;^UTILITY(U,$J,358.4,77,0)
;;=AUDITORY DISORDERS^2^14
;;^UTILITY(U,$J,358.4,78,0)
;;=BALANCE DISORDERS^3^14
;;^UTILITY(U,$J,358.4,79,0)
;;=BAROTRAUMA^4^14
;;^UTILITY(U,$J,358.4,80,0)
;;=EAR DISEASE^5^14
;;^UTILITY(U,$J,358.4,81,0)
;;=FOREIGN BODIES^7^14
;;^UTILITY(U,$J,358.4,82,0)
;;=HEARING LOSS^8^14
;;^UTILITY(U,$J,358.4,83,0)
;;=NOISE INJURIES^9^14
;;^UTILITY(U,$J,358.4,84,0)
;;=NYSTAGMUS^10^14
;;^UTILITY(U,$J,358.4,85,0)
;;=OTOTOXICITY^11^14
;;^UTILITY(U,$J,358.4,86,0)
;;=PURPOSE OF ENCOUNTER/HEALTH STATUS^12^14
;;^UTILITY(U,$J,358.4,87,0)
;;=EXTERNAL EAR DISEASES^6^14
;;^UTILITY(U,$J,358.4,88,0)
;;=NEW PATIENT^2^15
;;^UTILITY(U,$J,358.4,89,0)
;;=ESTABLISHED PATIENT^1^15
;;^UTILITY(U,$J,358.4,90,0)
;;=CONSULTATIONS^3^15
;;^UTILITY(U,$J,358.4,91,0)
;;=AUDIOLOGIC FUNCTION TESTS^1^16
;;^UTILITY(U,$J,358.4,92,0)
;;=SCREENING^13^16
;;^UTILITY(U,$J,358.4,93,0)
;;=COCHLEAR IMPLANT^3^16
;;^UTILITY(U,$J,358.4,94,0)
;;=OTHER TREATMENT^10^16
;;^UTILITY(U,$J,358.4,95,0)
;;=DISPENSING^5^16
;;^UTILITY(U,$J,358.4,96,0)
;;=REMOVAL FOREIGN BODY/CERUMEN^12^16
;;^UTILITY(U,$J,358.4,97,0)
;;=VESTIBULAR FUNCT W/ RECORDING^15^16
;;^UTILITY(U,$J,358.4,98,0)
;;=VESTIBULAR FUNCT W/O RECORDING^16^16
;;^UTILITY(U,$J,358.4,99,0)
;;=EVALUATIVE & THERAPEUTIC SVCS^6^16
;;^UTILITY(U,$J,358.4,100,0)
;;=TEAM CONFERENCE^14^16
;;^UTILITY(U,$J,358.4,101,0)
;;=PROLONGED CLINICAL STAFF SERVICES^11^16
;;^UTILITY(U,$J,358.4,102,0)
;;=OTHER SERVICES^9^16
;;^UTILITY(U,$J,358.4,103,0)
;;=DEVICES & EQUIPMENT^4^16
;;^UTILITY(U,$J,358.4,104,0)
;;=EXCISION^7^16
;;^UTILITY(U,$J,358.4,105,0)
;;=INCISION^8^16
;;^UTILITY(U,$J,358.4,106,0)
;;=AUTOMATED AUDIOMETRY^2^16
;;^UTILITY(U,$J,358.4,107,0)
;;=NEW PATIENT^2^17
;;^UTILITY(U,$J,358.4,108,0)
;;=ESTABLISHED PATIENT^1^17
;;^UTILITY(U,$J,358.4,109,0)
;;=CONSULTATIONS^3^17
;;^UTILITY(U,$J,358.4,110,0)
;;=ARRHYTHMIA^3^18
;;^UTILITY(U,$J,358.4,111,0)
;;=CHEST PAIN^4^18
;;^UTILITY(U,$J,358.4,112,0)
;;=CHF/MYOPATHY/TRANSPLANT^5^18
;;^UTILITY(U,$J,358.4,113,0)
;;=CORONARY ATHEROSCLEROSIS^6^18
;;^UTILITY(U,$J,358.4,114,0)
;;=GENERAL SYMPTOMS^9^18
;;^UTILITY(U,$J,358.4,115,0)
;;=HISTORY^12^18
;;^UTILITY(U,$J,358.4,116,0)
;;=HYPERTENSION/HYPOTENSION^13^18
;;^UTILITY(U,$J,358.4,117,0)
;;=INFECTION/INFLM DISEASE^14^18
;;^UTILITY(U,$J,358.4,118,0)
;;=LIPID DISORDER^15^18
;;^UTILITY(U,$J,358.4,119,0)
;;=MYOCARDIAL INFARCTION^17^18
;;^UTILITY(U,$J,358.4,120,0)
;;=NONRHEUMATIC HEART VALVE DISORDERS^18^18
;;^UTILITY(U,$J,358.4,121,0)
;;=HEART DISEASE^10^18
;;^UTILITY(U,$J,358.4,122,0)
;;=HEART VALVE DISEASE^11^18
;;^UTILITY(U,$J,358.4,123,0)
;;=PERIPHERAL VASC DISEASE^20^18
;;^UTILITY(U,$J,358.4,124,0)
;;=RHEUMATIC HEART DISEASE^23^18
;;^UTILITY(U,$J,358.4,125,0)
;;=DEVICE/IMPLANT/GRAFT^7^18
;;^UTILITY(U,$J,358.4,126,0)
;;=SYNCOPE^26^18
;;^UTILITY(U,$J,358.4,127,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^24^18
;;^UTILITY(U,$J,358.4,128,0)
;;=ECTOPY^8^18
;;^UTILITY(U,$J,358.4,129,0)
;;=MISCELLANEOUS^16^18
;;^UTILITY(U,$J,358.4,130,0)
;;=VENTRICULAR ARRHYTHMIAS^27^18
;;^UTILITY(U,$J,358.4,131,0)
;;=SUPRAVENTRICULAR ARRHYTHMIAS^25^18
;;^UTILITY(U,$J,358.4,132,0)
;;=OTHER CARDIAC CONDITIONS^22^18
;;^UTILITY(U,$J,358.4,133,0)
;;=PULMONARY DISEASE^21^18
;;^UTILITY(U,$J,358.4,134,0)
;;=PACEMAKER/AIC/DEFIBRILLATOR^19^18
;;^UTILITY(U,$J,358.4,135,0)
;;=ACSC CHF^1^18
;;^UTILITY(U,$J,358.4,136,0)
;;=ACSC HYPERTENSION^2^18
;;^UTILITY(U,$J,358.4,137,0)
;;=PACEMAKER^15^19
;;^UTILITY(U,$J,358.4,138,0)
;;=CORONARY ANGIOPLASTY & STENTS^3^19
;;^UTILITY(U,$J,358.4,139,0)
;;=ELECTROPHYSIOLOGICAL PROCs^7^19
;;^UTILITY(U,$J,358.4,140,0)
;;=PERIPHERAL ANGIOPLASTIES & STENTS^16^19
;;^UTILITY(U,$J,358.4,141,0)
;;=VASCULAR INJECTION PROCs^21^19
;;^UTILITY(U,$J,358.4,142,0)
;;=OTHER PROCEDURES^14^19
;;^UTILITY(U,$J,358.4,143,0)
;;=HEART CATHETERIZATIONS^8^19
;;^UTILITY(U,$J,358.4,144,0)
;;=CATHETERIZATIONS FOR INT RADIOLOGY^2^19
;;^UTILITY(U,$J,358.4,145,0)
;;=OTHER HEART CODES^13^19
;;^UTILITY(U,$J,358.4,146,0)
;;=PROSTHETIC ANEURYSM REPAIR^19^19
;;^UTILITY(U,$J,358.4,147,0)
;;=DEVICE PROGRAMMING^4^19
;;^UTILITY(U,$J,358.4,148,0)
;;=ECHO^5^19
;;^UTILITY(U,$J,358.4,149,0)
;;=EKG^6^19
;;^UTILITY(U,$J,358.4,150,0)
;;=MEDICATION ADMINISTRATION^9^19
;;^UTILITY(U,$J,358.4,151,0)
;;=MEDICATIONS^10^19
;;^UTILITY(U,$J,358.4,152,0)
;;=OTHER CARDIAC^12^19
;;^UTILITY(U,$J,358.4,153,0)
;;=STRESS TESTS^20^19
;;^UTILITY(U,$J,358.4,154,0)
;;=PREVENTIVE COUNSELING^17^19
;;^UTILITY(U,$J,358.4,155,0)
;;=MODERATE SEDATION (MS)^11^19
;;^UTILITY(U,$J,358.4,156,0)
;;=VENTRICULAR ASSIST DEVICE INSERTION^22^19
;;^UTILITY(U,$J,358.4,157,0)
;;=CARDIOVERSION^1^19
;;^UTILITY(U,$J,358.4,158,0)
;;=PROLONGED SERVICES^18^19
;;^UTILITY(U,$J,358.4,159,0)
;;=COUNSELING/EDUCATION^5^20
;;^UTILITY(U,$J,358.4,160,0)
;;=PSYCHIATRIC THERAPY^10^20
;;^UTILITY(U,$J,358.4,161,0)
;;=BIOFEEDBACK THERAPY^2^20
;;^UTILITY(U,$J,358.4,162,0)
;;=BIOPSYCHOSOCIAL ASSESS/INTERVENTION^3^20
;;^UTILITY(U,$J,358.4,163,0)
;;=PHYSICAL THERAPY^9^20
;;^UTILITY(U,$J,358.4,164,0)
;;=OTHER THERAPEUTIC TECHNIQUES^8^20
;;^UTILITY(U,$J,358.4,165,0)
;;=ACUPUNTURE^1^20
;;^UTILITY(U,$J,358.4,166,0)
;;=OSTEOPATHIC MANIPULATION^7^20
;;^UTILITY(U,$J,358.4,167,0)
;;=CHIROPRACTIC MANIPULATION^4^20
;;^UTILITY(U,$J,358.4,168,0)
;;=SELF-MANAGEMENT TRAINING^11^20
;;^UTILITY(U,$J,358.4,169,0)
;;=NUTRITION APPROACHES^6^20
;;^UTILITY(U,$J,358.4,170,0)
;;=VA WHOLE HEALTH PARTNER SVCS^12^20
;;^UTILITY(U,$J,358.4,171,0)
;;=COUNSELING^2^21
;;^UTILITY(U,$J,358.4,172,0)
;;=HISTORY OF ILLNESS^7^21
;;^UTILITY(U,$J,358.4,173,0)
;;=OTHER^19^21
;;^UTILITY(U,$J,358.4,174,0)
;;=SCREENING^14^21
;;^UTILITY(U,$J,358.4,175,0)
;;=CARDIOVASCULAR DISORDER^1^21
;;^UTILITY(U,$J,358.4,176,0)
;;=DIABETIC MANAGEMENT^3^21
;;^UTILITY(U,$J,358.4,177,0)
;;=ENDOCRINE DISORDER^4^21
;;^UTILITY(U,$J,358.4,178,0)
;;=HEARING DISORDER^6^21
;;^UTILITY(U,$J,358.4,179,0)
;;=GASTROINTESTINAL DISORDER^5^21
;;^UTILITY(U,$J,358.4,180,0)
;;=INJURIES^8^21
;;^UTILITY(U,$J,358.4,181,0)
;;=NEOPLASM^11^21
;;^UTILITY(U,$J,358.4,182,0)
;;=RESPIRATORY DISORDER^13^21
;;^UTILITY(U,$J,358.4,183,0)
;;=SIGNS AND SYMPTOMS^15^21
;;^UTILITY(U,$J,358.4,184,0)
;;=SUBSTANCE DISORDERS^16^21
;;^UTILITY(U,$J,358.4,185,0)
;;=WEIGHT MANAGEMENT^18^21
;;^UTILITY(U,$J,358.4,186,0)
;;=MOOD DISORDER^9^21
;;^UTILITY(U,$J,358.4,187,0)
;;=MUSCULOSKELETAL DISORDER^10^21
;;^UTILITY(U,$J,358.4,188,0)
;;=NEUROLOGICAL^12^21
;;^UTILITY(U,$J,358.4,189,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^17^21
;;^UTILITY(U,$J,358.4,190,0)
;;=ESTABLISHED PATIENT^1^22
;;^UTILITY(U,$J,358.4,191,0)
;;=NEW PATIENT^2^22
;;^UTILITY(U,$J,358.4,192,0)
;;=NEW PATIENT^2^24
;;^UTILITY(U,$J,358.4,193,0)
;;=ESTABLISHED PATIENT^1^24
;;^UTILITY(U,$J,358.4,194,0)
;;=CONSULTATIONS^3^24
;;^UTILITY(U,$J,358.4,195,0)
;;=POST-OP FOLLOW-UP^4^24
;;^UTILITY(U,$J,358.4,196,0)
;;=DEBRIDEMENT^2^25
;;^UTILITY(U,$J,358.4,197,0)
;;=DESTR-BENIGN/PREMALIGNANT^6^25
;;^UTILITY(U,$J,358.4,198,0)
;;=DEST MAL LESION-TRUNK,ARMS,LEGS^5^25
;;^UTILITY(U,$J,358.4,199,0)
;;=EXC-BEN LESION-TRUNK,ARM,LEG^10^25
;;^UTILITY(U,$J,358.4,200,0)
;;=EXC-MAL LESION-TRUNK,ARM,LEG^13^25
;;^UTILITY(U,$J,358.4,201,0)
;;=INCISION & DRAINAGE^15^25
;;^UTILITY(U,$J,358.4,202,0)
;;=MISCELLANEOUS^18^25
;;^UTILITY(U,$J,358.4,203,0)
;;=NAILS^20^25
;;^UTILITY(U,$J,358.4,204,0)
;;=SHAVING-EPIDERMAL-TRUNK,ARM,LEG^34^25
;;^UTILITY(U,$J,358.4,205,0)
;;=REPAIR-SIMPLE-SCALP,NK,TRUNK^31^25
;;^UTILITY(U,$J,358.4,206,0)
;;=REPAIR-INTERM-SCALP,TRUNK^29^25
;;^UTILITY(U,$J,358.4,207,0)
;;=DEST MAL LES-SCALP,NK,HAND,FEET,GENITALS^4^25
;;^UTILITY(U,$J,358.4,208,0)
;;=DEST MAL LESION-FACE,MUCOUS^3^25
;;^UTILITY(U,$J,358.4,209,0)
;;=EXC-BEN LESION-SCALP,HANDS,FT,GENITALS^9^25
;;^UTILITY(U,$J,358.4,210,0)
;;=EXC-BEN LESION-FACE,MUCOUS^8^25
;;^UTILITY(U,$J,358.4,211,0)
;;=EXC-MAL LESION-SCALP,NK,HAND,FT,GENITALS^12^25
;;^UTILITY(U,$J,358.4,212,0)
;;=EXC-MAL LESION-FACE,MUCOUS^11^25
;;^UTILITY(U,$J,358.4,213,0)
;;=SHAVING-EPIDERM-SCALP,NK,HAND,FT,GENITAL^33^25
;;^UTILITY(U,$J,358.4,214,0)
;;=SHAVING-EPIDERM-FACE,MUCOUS^32^25
;;^UTILITY(U,$J,358.4,215,0)
;;=REPAIR-SIMPLE-FACE,MUCOUS^30^25
;;^UTILITY(U,$J,358.4,216,0)
;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^28^25
;;^UTILITY(U,$J,358.4,217,0)
;;=REPAIR-INTERM-FACE,MUCOUS^27^25
;;^UTILITY(U,$J,358.4,218,0)
;;=WOUND HEALING^42^25
;;^UTILITY(U,$J,358.4,219,0)
;;=SKIN TEST^36^25
;;^UTILITY(U,$J,358.4,220,0)
;;=MICROBIOLOGY^17^25
;;^UTILITY(U,$J,358.4,221,0)
;;=MOHS CHEMOSURGERY^19^25
;;^UTILITY(U,$J,358.4,222,0)
;;=INJECTIONS^16^25
;;^UTILITY(U,$J,358.4,223,0)
;;=PEEL^21^25
;;^UTILITY(U,$J,358.4,224,0)
;;=PHOTOTHERAPY^22^25
;;^UTILITY(U,$J,358.4,225,0)
;;=REPAIR-COMPLEX-FACE^23^25
;;^UTILITY(U,$J,358.4,226,0)
;;=REPAIR-COMPLEX-NK/HAND/FT^24^25
;;^UTILITY(U,$J,358.4,227,0)
;;=REPAIR-COMPLEX-TRUNK^26^25
;;^UTILITY(U,$J,358.4,228,0)
;;=TISSUE REARRANGMNT-FACE/NECK/HAND/FOOT^39^25
;;^UTILITY(U,$J,358.4,229,0)
;;=TISSUE REARRANGMNT-SCALP/ARMS/LEGS^40^25
;;^UTILITY(U,$J,358.4,230,0)
;;=TISSUE REARRANGMNT-TRUNK^41^25
;;^UTILITY(U,$J,358.4,231,0)
;;=REPAIR-COMPLEX-SCALP^25^25
;;^UTILITY(U,$J,358.4,232,0)
;;=TISSUE REARRANGMNT-EYELID/NOSE/EAR/LIP^38^25
;;^UTILITY(U,$J,358.4,233,0)
;;=BIOPSY^1^25
;;^UTILITY(U,$J,358.4,234,0)
;;=TISSUE REARRANGEMENT-ANY AREA^37^25
;;^UTILITY(U,$J,358.4,235,0)
;;=SKIN GRAFT/AUTOGRAFT^35^25
;;^UTILITY(U,$J,358.4,236,0)
;;=DESTR-CUT VASC PROLIFERATION^7^25
;;^UTILITY(U,$J,358.4,237,0)
;;=FINE NEEDLE ASPIRATION BIOPSY^14^25
;;^UTILITY(U,$J,358.4,238,0)
;;=A DIAGNOSES^2^26
;;^UTILITY(U,$J,358.4,239,0)
;;=D DIAGNOSES^5^26
;;^UTILITY(U,$J,358.4,240,0)
;;=E DIAGNOSES^6^26
;;^UTILITY(U,$J,358.4,241,0)
;;=F DIAGNOSES^7^26
;;^UTILITY(U,$J,358.4,242,0)
;;=I DIAGNOSES^10^26
;;^UTILITY(U,$J,358.4,243,0)
;;=K DIAGNOSES^11^26
;;^UTILITY(U,$J,358.4,244,0)
;;=M DIAGNOSES^13^26
;;^UTILITY(U,$J,358.4,245,0)
;;=N DIAGNOSES^14^26
;;^UTILITY(U,$J,358.4,246,0)
;;=P DIAGNOSES^16^26
;;^UTILITY(U,$J,358.4,247,0)
;;=R DIAGNOSES^17^26
;;^UTILITY(U,$J,358.4,248,0)
;;=S DIAGNOSES^18^26
;;^UTILITY(U,$J,358.4,249,0)
;;=T DIAGNOSES^20^26
;;^UTILITY(U,$J,358.4,250,0)
;;=V DIAGNOSES^22^26
;;^UTILITY(U,$J,358.4,251,0)
;;=X DIAGNOSES^24^26
;;^UTILITY(U,$J,358.4,252,0)
;;=C DIAGNOSES^4^26
;;^UTILITY(U,$J,358.4,253,0)
;;=W DIAGNOSES^23^26
;;^UTILITY(U,$J,358.4,254,0)
;;=B DIAGNOSES^3^26
;;^UTILITY(U,$J,358.4,255,0)
;;=G DIAGNOSES^8^26
;;^UTILITY(U,$J,358.4,256,0)
;;=H DIAGNOSES^8^26
;;^UTILITY(U,$J,358.4,257,0)
;;=L DIAGNOSES^12^26
;;^UTILITY(U,$J,358.4,258,0)
;;=O DIAGNOSES^15^26
;;^UTILITY(U,$J,358.4,259,0)
;;=U DIAGNOSES^21^26
;;^UTILITY(U,$J,358.4,260,0)
;;=Z DIAGNOSES^25^26
;;^UTILITY(U,$J,358.4,261,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^19^26
;;^UTILITY(U,$J,358.4,262,0)
;;=MOST COMMON DX^1^26
;;^UTILITY(U,$J,358.4,263,0)
;;=NEW PATIENT^3^27
;;^UTILITY(U,$J,358.4,264,0)
;;=ESTABLISHED PATIENT^1^27
;;^UTILITY(U,$J,358.4,265,0)
;;=CONSULTATIONS^2^27
;;^UTILITY(U,$J,358.4,266,0)
;;=PREVENTIVE MEDICINE-EST PT^4^27
;;^UTILITY(U,$J,358.4,267,0)
;;=PREVENTIVE MEDICINE-NEW PT^5^27
;;^UTILITY(U,$J,358.4,268,0)
;;=RISK FACTOR REDUCTION-GRP^6^27
;;^UTILITY(U,$J,358.4,269,0)
;;=RISK FACTOR REDUCTION-IND^7^27
;;^UTILITY(U,$J,358.4,270,0)
;;=OTHER^3^28
;;^UTILITY(U,$J,358.4,271,0)
;;=EDUCATION/TRAINING^1^28
;;^UTILITY(U,$J,358.4,272,0)
;;=MEDICAL NUTRITION THERAPY^2^28
;;^UTILITY(U,$J,358.4,273,0)
;;=WOUND TREATMENT^5^28
;;^UTILITY(U,$J,358.4,274,0)
;;=PROLONGED SERVICES^4^28
;;^UTILITY(U,$J,358.4,275,0)
;;=DIABETES^1^29
;;^UTILITY(U,$J,358.4,276,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^2^29
;;^UTILITY(U,$J,358.4,277,0)
;;=NEW PATIENT^2^30
;;^UTILITY(U,$J,358.4,278,0)
;;=ESTABLISHED PATIENT^1^30
;;^UTILITY(U,$J,358.4,279,0)
;;=CONSULTATIONS^3^30
;;^UTILITY(U,$J,358.4,280,0)
;;=ENDOCRINE DX^1^31
;;^UTILITY(U,$J,358.4,281,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^2^31
;;^UTILITY(U,$J,358.4,282,0)
;;=BIOPSIES^1^32
;;^UTILITY(U,$J,358.4,283,0)
;;=INJECTIONS & INFUSIONS^2^32
;;^UTILITY(U,$J,358.4,284,0)
;;=OTHER^4^32
;;^UTILITY(U,$J,358.4,285,0)
;;=PROLONGED CLINICAL STAFF SERVICES^5^32
;;^UTILITY(U,$J,358.4,286,0)
;;=LAB TESTS^3^32
;;^UTILITY(U,$J,358.4,287,0)
;;=NEW PATIENT^3^33
;;^UTILITY(U,$J,358.4,288,0)
;;=ESTABLISHED PATIENT^2^33
;;^UTILITY(U,$J,358.4,289,0)
;;=CONSULTS - OUTPT^4^33
;;^UTILITY(U,$J,358.4,290,0)
;;=EYE CODES^1^33
;;^UTILITY(U,$J,358.4,291,0)
;;=CONSULTS - INPT^5^33
;;^UTILITY(U,$J,358.4,292,0)
;;=HOSPITAL CARE - INITIAL^6^33
;;^UTILITY(U,$J,358.4,293,0)
;;=HOSPITAL CARE - SUBSEQUENT^7^33
;;^UTILITY(U,$J,358.4,294,0)
;;=HOSPITAL CARE - DISCHARGE^8^33
;;^UTILITY(U,$J,358.4,295,0)
;;=OBSERVATION CARE - INITIAL^9^33
;;^UTILITY(U,$J,358.4,296,0)
;;=OBSERVATION CARE - SUBSEQUENT^10^33
;;^UTILITY(U,$J,358.4,297,0)
;;=OBSERVATION CARE - DISCHARGE^11^33
;;^UTILITY(U,$J,358.4,298,0)
;;=INPT or OBS - ADMIT & DISCHARGE SAME DAY^12^33
;;^UTILITY(U,$J,358.4,299,0)
;;=EEF Version 2022 April^13^33
;;^UTILITY(U,$J,358.4,300,0)
;;=PROC - LID / LACRIMAL^7^34
;;^UTILITY(U,$J,358.4,301,0)
;;=PROC - LASER / CRYO^10^34
;;^UTILITY(U,$J,358.4,302,0)
;;=PROC - CORNEA / CONJ^6^34
;;^UTILITY(U,$J,358.4,303,0)
;;=MEDICATIONS^12^34
;;^UTILITY(U,$J,358.4,304,0)
;;=PROC - INJECTIONS / ALL^9^34
;;^UTILITY(U,$J,358.4,305,0)
;;=IMAGE / PHOTOS^2^34
;;^UTILITY(U,$J,358.4,306,0)
;;=REFRACT / GLASSES / CL^1^34
;;^UTILITY(U,$J,358.4,307,0)
;;=TEST - CATARACT / CORNEA^4^34
;;^UTILITY(U,$J,358.4,308,0)
;;=TEST - GLAUCOMA^3^34
;;^UTILITY(U,$J,358.4,309,0)
;;=TEST - OTHER^5^34
;;^UTILITY(U,$J,358.4,310,0)
;;=EDUCATION / COUNSELING^13^34
;;^UTILITY(U,$J,358.4,311,0)
;;=EYE SURGERY CODES^11^34
;;^UTILITY(U,$J,358.4,312,0)
;;=PROC - INJECTIONS / VEGF^8^34
;;^UTILITY(U,$J,358.4,313,0)
;;=TEST - ERG / VEP^14^34
;;^UTILITY(U,$J,358.4,314,0)
;;=LOW VISION / BLINDNESS^21^35
;;^UTILITY(U,$J,358.4,315,0)
;;=RETINA - VASCULAR^12^35
;;^UTILITY(U,$J,358.4,316,0)
;;=EYELIDS / LASHES^2^35
;;^UTILITY(U,$J,358.4,317,0)
;;=NEURO / STRABISMUS^18^35
;;^UTILITY(U,$J,358.4,318,0)
;;=ORBIT - PLASTICS^20^35
;;^UTILITY(U,$J,358.4,319,0)
;;=VITREOUS^17^35
;;^UTILITY(U,$J,358.4,320,0)
;;=ORBIT - TRAUMA^19^35
;;^UTILITY(U,$J,358.4,321,0)
;;=LACRIMAL / NLD / NEOPLASMS^3^35
;;^UTILITY(U,$J,358.4,322,0)
;;=MOST FREQUENT^1^35
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0FN 19769 printed Sep 23, 2025@19:23:44 Page 2
IBDEI0FN ; ; 03-MAY-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4)
+2 ;;=^IBE(358.4,
+3 ;;^UTILITY(U,$J,358.4,0)
+4 ;;=IMP/EXP SELECTION GROUP^358.4I^1536^1504
+5 ;;^UTILITY(U,$J,358.4,1,0)
+6 ;;=NEW PATIENT^2^1
+7 ;;^UTILITY(U,$J,358.4,2,0)
+8 ;;=ESTABLISHED PATIENT^1^1
+9 ;;^UTILITY(U,$J,358.4,3,0)
+10 ;;=CONSULTATIONS^3^1
+11 ;;^UTILITY(U,$J,358.4,4,0)
+12 ;;=ALLERGY DIAGNOSES^1^2
+13 ;;^UTILITY(U,$J,358.4,5,0)
+14 ;;=IMMUNODEFICIENCY^2^2
+15 ;;^UTILITY(U,$J,358.4,6,0)
+16 ;;=OTHER^3^2
+17 ;;^UTILITY(U,$J,358.4,7,0)
+18 ;;=IMMUNIZATION^4^3
+19 ;;^UTILITY(U,$J,358.4,8,0)
+20 ;;=SKIN TEST^9^3
+21 ;;^UTILITY(U,$J,358.4,9,0)
+22 ;;=ALLERGENIC EXTRACT^1^3
+23 ;;^UTILITY(U,$J,358.4,10,0)
+24 ;;=PATCH TESTS^8^3
+25 ;;^UTILITY(U,$J,358.4,11,0)
+26 ;;=ALLERGY INJECTION/EXTRACT^2^3
+27 ;;^UTILITY(U,$J,358.4,12,0)
+28 ;;=LABORATORY^6^3
+29 ;;^UTILITY(U,$J,358.4,13,0)
+30 ;;=INFUSIONS^5^3
+31 ;;^UTILITY(U,$J,358.4,14,0)
+32 ;;=OTHER^7^3
+33 ;;^UTILITY(U,$J,358.4,15,0)
+34 ;;=EDUCATION/TRAINING^1^4
+35 ;;^UTILITY(U,$J,358.4,16,0)
+36 ;;=FAMILY TRAINING-GROUP^2^4
+37 ;;^UTILITY(U,$J,358.4,17,0)
+38 ;;=PROCEDURE CODES-GROUP^3^4
+39 ;;^UTILITY(U,$J,358.4,18,0)
+40 ;;=RECREATION THERAPY DX^1^5
+41 ;;^UTILITY(U,$J,358.4,19,0)
+42 ;;=SDOH^2^5
+43 ;;^UTILITY(U,$J,358.4,20,0)
+44 ;;=1-1 THERAPEUTIC PROCEDURES^1^6
+45 ;;^UTILITY(U,$J,358.4,21,0)
+46 ;;=EDUCATION/TRAINING^3^6
+47 ;;^UTILITY(U,$J,358.4,22,0)
+48 ;;=TEAM CONFERENCE^6^6
+49 ;;^UTILITY(U,$J,358.4,23,0)
+50 ;;=ASSESSMENT^2^6
+51 ;;^UTILITY(U,$J,358.4,24,0)
+52 ;;=FAMILY TRAINING^4^6
+53 ;;^UTILITY(U,$J,358.4,25,0)
+54 ;;=SPECIALTY PROCEDURES-INDIVIDUAL^5^6
+55 ;;^UTILITY(U,$J,358.4,26,0)
+56 ;;=RECREATION THERAPY DX^1^7
+57 ;;^UTILITY(U,$J,358.4,27,0)
+58 ;;=SDOH^2^7
+59 ;;^UTILITY(U,$J,358.4,28,0)
+60 ;;=SPECIAL SERVICES^10^8
+61 ;;^UTILITY(U,$J,358.4,29,0)
+62 ;;=CHEMO NURSE PROCEDURES^2^8
+63 ;;^UTILITY(U,$J,358.4,30,0)
+64 ;;=INFUSION DRUGS^7^8
+65 ;;^UTILITY(U,$J,358.4,31,0)
+66 ;;=BLOOD PRODUCTS^1^8
+67 ;;^UTILITY(U,$J,358.4,32,0)
+68 ;;=DIAGNOSTIC PROCEDURES^3^8
+69 ;;^UTILITY(U,$J,358.4,33,0)
+70 ;;=OTHER DRUGS^8^8
+71 ;;^UTILITY(U,$J,358.4,34,0)
+72 ;;=IMMUNIZATION ADMINISTRATION^5^8
+73 ;;^UTILITY(U,$J,358.4,35,0)
+74 ;;=IMMUNIZATIONS^6^8
+75 ;;^UTILITY(U,$J,358.4,36,0)
+76 ;;=PROLONGED SVC-MD/NP/PA^9^8
+77 ;;^UTILITY(U,$J,358.4,37,0)
+78 ;;=EDUCATION/TRAINING^4^8
+79 ;;^UTILITY(U,$J,358.4,38,0)
+80 ;;=NEW PATIENT^2^9
+81 ;;^UTILITY(U,$J,358.4,39,0)
+82 ;;=ESTABLISHED PATIENT^1^9
+83 ;;^UTILITY(U,$J,358.4,40,0)
+84 ;;=CONSULTATIONS^3^9
+85 ;;^UTILITY(U,$J,358.4,41,0)
+86 ;;=COMPLEX CHRONIC CARE^4^9
+87 ;;^UTILITY(U,$J,358.4,42,0)
+88 ;;=ANEMIA^1^10
+89 ;;^UTILITY(U,$J,358.4,43,0)
+90 ;;=ARTIFICIAL OPENING STATUS^2^10
+91 ;;^UTILITY(U,$J,358.4,44,0)
+92 ;;=BREASTS and GYN NEOPLASMS^3^10
+93 ;;^UTILITY(U,$J,358.4,45,0)
+94 ;;=COAGULATION DISORDERS^4^10
+95 ;;^UTILITY(U,$J,358.4,46,0)
+96 ;;=COUNSELING AND SCREENING^5^10
+97 ;;^UTILITY(U,$J,358.4,47,0)
+98 ;;=GENITOURINARY NEOPLASMS^6^10
+99 ;;^UTILITY(U,$J,358.4,48,0)
+100 ;;=GI CANCER^7^10
+101 ;;^UTILITY(U,$J,358.4,49,0)
+102 ;;=HEAD NECK AND LUNGS NEOPLASMS^8^10
+103 ;;^UTILITY(U,$J,358.4,50,0)
+104 ;;=HEMOGLOBINOPATHIES^9^10
+105 ;;^UTILITY(U,$J,358.4,51,0)
+106 ;;=LYMPHOID NEOPLASMS^10^10
+107 ;;^UTILITY(U,$J,358.4,52,0)
+108 ;;=METASTATIC SITES^13^10
+109 ;;^UTILITY(U,$J,358.4,53,0)
+110 ;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^10
+111 ;;^UTILITY(U,$J,358.4,54,0)
+112 ;;=MYELOID NEOPLASMS AND DISORDERS^14^10
+113 ;;^UTILITY(U,$J,358.4,55,0)
+114 ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^10
+115 ;;^UTILITY(U,$J,358.4,56,0)
+116 ;;=NEOPLASM OF UNSPECIFIED NATURE^16^10
+117 ;;^UTILITY(U,$J,358.4,57,0)
+118 ;;=PERSONAL HISTORY^19^10
+119 ;;^UTILITY(U,$J,358.4,58,0)
+120 ;;=MALNUTRITION^12^10
+121 ;;^UTILITY(U,$J,358.4,59,0)
+122 ;;=OTHER^18^10
+123 ;;^UTILITY(U,$J,358.4,60,0)
+124 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^10
+125 ;;^UTILITY(U,$J,358.4,61,0)
+126 ;;=ESTABLISHED PATIENT^1^11
+127 ;;^UTILITY(U,$J,358.4,62,0)
+128 ;;=CARE PLAN OVERSIGHT^1^12
+129 ;;^UTILITY(U,$J,358.4,63,0)
+130 ;;=OTHER SERVICES^4^12
+131 ;;^UTILITY(U,$J,358.4,64,0)
+132 ;;=CASE MANAGEMENT^2^12
+133 ;;^UTILITY(U,$J,358.4,65,0)
+134 ;;=EDUCATION^3^12
+135 ;;^UTILITY(U,$J,358.4,66,0)
+136 ;;=CARDIOVASCULAR DISORDERS^1^13
+137 ;;^UTILITY(U,$J,358.4,67,0)
+138 ;;=CONDITIONS AFFECTING HEALTH CARE STATUS^2^13
+139 ;;^UTILITY(U,$J,358.4,68,0)
+140 ;;=DIABETES^4^13
+141 ;;^UTILITY(U,$J,358.4,69,0)
+142 ;;=EYE & EAR DISORDERS^4^13
+143 ;;^UTILITY(U,$J,358.4,70,0)
+144 ;;=MENTAL HEALTH^5^13
+145 ;;^UTILITY(U,$J,358.4,71,0)
+146 ;;=NEOPLASMS^6^13
+147 ;;^UTILITY(U,$J,358.4,72,0)
+148 ;;=NEUROLOGICAL CONDITIONS^7^13
+149 ;;^UTILITY(U,$J,358.4,73,0)
+150 ;;=OTHER CONDITIONS^8^13
+151 ;;^UTILITY(U,$J,358.4,74,0)
+152 ;;=RESPIRATORY DISORDERS^9^13
+153 ;;^UTILITY(U,$J,358.4,75,0)
+154 ;;=DEMENTIA^3^13
+155 ;;^UTILITY(U,$J,358.4,76,0)
+156 ;;=ACOUSTIC NERVE INJURIES^1^14
+157 ;;^UTILITY(U,$J,358.4,77,0)
+158 ;;=AUDITORY DISORDERS^2^14
+159 ;;^UTILITY(U,$J,358.4,78,0)
+160 ;;=BALANCE DISORDERS^3^14
+161 ;;^UTILITY(U,$J,358.4,79,0)
+162 ;;=BAROTRAUMA^4^14
+163 ;;^UTILITY(U,$J,358.4,80,0)
+164 ;;=EAR DISEASE^5^14
+165 ;;^UTILITY(U,$J,358.4,81,0)
+166 ;;=FOREIGN BODIES^7^14
+167 ;;^UTILITY(U,$J,358.4,82,0)
+168 ;;=HEARING LOSS^8^14
+169 ;;^UTILITY(U,$J,358.4,83,0)
+170 ;;=NOISE INJURIES^9^14
+171 ;;^UTILITY(U,$J,358.4,84,0)
+172 ;;=NYSTAGMUS^10^14
+173 ;;^UTILITY(U,$J,358.4,85,0)
+174 ;;=OTOTOXICITY^11^14
+175 ;;^UTILITY(U,$J,358.4,86,0)
+176 ;;=PURPOSE OF ENCOUNTER/HEALTH STATUS^12^14
+177 ;;^UTILITY(U,$J,358.4,87,0)
+178 ;;=EXTERNAL EAR DISEASES^6^14
+179 ;;^UTILITY(U,$J,358.4,88,0)
+180 ;;=NEW PATIENT^2^15
+181 ;;^UTILITY(U,$J,358.4,89,0)
+182 ;;=ESTABLISHED PATIENT^1^15
+183 ;;^UTILITY(U,$J,358.4,90,0)
+184 ;;=CONSULTATIONS^3^15
+185 ;;^UTILITY(U,$J,358.4,91,0)
+186 ;;=AUDIOLOGIC FUNCTION TESTS^1^16
+187 ;;^UTILITY(U,$J,358.4,92,0)
+188 ;;=SCREENING^13^16
+189 ;;^UTILITY(U,$J,358.4,93,0)
+190 ;;=COCHLEAR IMPLANT^3^16
+191 ;;^UTILITY(U,$J,358.4,94,0)
+192 ;;=OTHER TREATMENT^10^16
+193 ;;^UTILITY(U,$J,358.4,95,0)
+194 ;;=DISPENSING^5^16
+195 ;;^UTILITY(U,$J,358.4,96,0)
+196 ;;=REMOVAL FOREIGN BODY/CERUMEN^12^16
+197 ;;^UTILITY(U,$J,358.4,97,0)
+198 ;;=VESTIBULAR FUNCT W/ RECORDING^15^16
+199 ;;^UTILITY(U,$J,358.4,98,0)
+200 ;;=VESTIBULAR FUNCT W/O RECORDING^16^16
+201 ;;^UTILITY(U,$J,358.4,99,0)
+202 ;;=EVALUATIVE & THERAPEUTIC SVCS^6^16
+203 ;;^UTILITY(U,$J,358.4,100,0)
+204 ;;=TEAM CONFERENCE^14^16
+205 ;;^UTILITY(U,$J,358.4,101,0)
+206 ;;=PROLONGED CLINICAL STAFF SERVICES^11^16
+207 ;;^UTILITY(U,$J,358.4,102,0)
+208 ;;=OTHER SERVICES^9^16
+209 ;;^UTILITY(U,$J,358.4,103,0)
+210 ;;=DEVICES & EQUIPMENT^4^16
+211 ;;^UTILITY(U,$J,358.4,104,0)
+212 ;;=EXCISION^7^16
+213 ;;^UTILITY(U,$J,358.4,105,0)
+214 ;;=INCISION^8^16
+215 ;;^UTILITY(U,$J,358.4,106,0)
+216 ;;=AUTOMATED AUDIOMETRY^2^16
+217 ;;^UTILITY(U,$J,358.4,107,0)
+218 ;;=NEW PATIENT^2^17
+219 ;;^UTILITY(U,$J,358.4,108,0)
+220 ;;=ESTABLISHED PATIENT^1^17
+221 ;;^UTILITY(U,$J,358.4,109,0)
+222 ;;=CONSULTATIONS^3^17
+223 ;;^UTILITY(U,$J,358.4,110,0)
+224 ;;=ARRHYTHMIA^3^18
+225 ;;^UTILITY(U,$J,358.4,111,0)
+226 ;;=CHEST PAIN^4^18
+227 ;;^UTILITY(U,$J,358.4,112,0)
+228 ;;=CHF/MYOPATHY/TRANSPLANT^5^18
+229 ;;^UTILITY(U,$J,358.4,113,0)
+230 ;;=CORONARY ATHEROSCLEROSIS^6^18
+231 ;;^UTILITY(U,$J,358.4,114,0)
+232 ;;=GENERAL SYMPTOMS^9^18
+233 ;;^UTILITY(U,$J,358.4,115,0)
+234 ;;=HISTORY^12^18
+235 ;;^UTILITY(U,$J,358.4,116,0)
+236 ;;=HYPERTENSION/HYPOTENSION^13^18
+237 ;;^UTILITY(U,$J,358.4,117,0)
+238 ;;=INFECTION/INFLM DISEASE^14^18
+239 ;;^UTILITY(U,$J,358.4,118,0)
+240 ;;=LIPID DISORDER^15^18
+241 ;;^UTILITY(U,$J,358.4,119,0)
+242 ;;=MYOCARDIAL INFARCTION^17^18
+243 ;;^UTILITY(U,$J,358.4,120,0)
+244 ;;=NONRHEUMATIC HEART VALVE DISORDERS^18^18
+245 ;;^UTILITY(U,$J,358.4,121,0)
+246 ;;=HEART DISEASE^10^18
+247 ;;^UTILITY(U,$J,358.4,122,0)
+248 ;;=HEART VALVE DISEASE^11^18
+249 ;;^UTILITY(U,$J,358.4,123,0)
+250 ;;=PERIPHERAL VASC DISEASE^20^18
+251 ;;^UTILITY(U,$J,358.4,124,0)
+252 ;;=RHEUMATIC HEART DISEASE^23^18
+253 ;;^UTILITY(U,$J,358.4,125,0)
+254 ;;=DEVICE/IMPLANT/GRAFT^7^18
+255 ;;^UTILITY(U,$J,358.4,126,0)
+256 ;;=SYNCOPE^26^18
+257 ;;^UTILITY(U,$J,358.4,127,0)
+258 ;;=SUICIDE IDEATIONS/ATTEMPTS^24^18
+259 ;;^UTILITY(U,$J,358.4,128,0)
+260 ;;=ECTOPY^8^18
+261 ;;^UTILITY(U,$J,358.4,129,0)
+262 ;;=MISCELLANEOUS^16^18
+263 ;;^UTILITY(U,$J,358.4,130,0)
+264 ;;=VENTRICULAR ARRHYTHMIAS^27^18
+265 ;;^UTILITY(U,$J,358.4,131,0)
+266 ;;=SUPRAVENTRICULAR ARRHYTHMIAS^25^18
+267 ;;^UTILITY(U,$J,358.4,132,0)
+268 ;;=OTHER CARDIAC CONDITIONS^22^18
+269 ;;^UTILITY(U,$J,358.4,133,0)
+270 ;;=PULMONARY DISEASE^21^18
+271 ;;^UTILITY(U,$J,358.4,134,0)
+272 ;;=PACEMAKER/AIC/DEFIBRILLATOR^19^18
+273 ;;^UTILITY(U,$J,358.4,135,0)
+274 ;;=ACSC CHF^1^18
+275 ;;^UTILITY(U,$J,358.4,136,0)
+276 ;;=ACSC HYPERTENSION^2^18
+277 ;;^UTILITY(U,$J,358.4,137,0)
+278 ;;=PACEMAKER^15^19
+279 ;;^UTILITY(U,$J,358.4,138,0)
+280 ;;=CORONARY ANGIOPLASTY & STENTS^3^19
+281 ;;^UTILITY(U,$J,358.4,139,0)
+282 ;;=ELECTROPHYSIOLOGICAL PROCs^7^19
+283 ;;^UTILITY(U,$J,358.4,140,0)
+284 ;;=PERIPHERAL ANGIOPLASTIES & STENTS^16^19
+285 ;;^UTILITY(U,$J,358.4,141,0)
+286 ;;=VASCULAR INJECTION PROCs^21^19
+287 ;;^UTILITY(U,$J,358.4,142,0)
+288 ;;=OTHER PROCEDURES^14^19
+289 ;;^UTILITY(U,$J,358.4,143,0)
+290 ;;=HEART CATHETERIZATIONS^8^19
+291 ;;^UTILITY(U,$J,358.4,144,0)
+292 ;;=CATHETERIZATIONS FOR INT RADIOLOGY^2^19
+293 ;;^UTILITY(U,$J,358.4,145,0)
+294 ;;=OTHER HEART CODES^13^19
+295 ;;^UTILITY(U,$J,358.4,146,0)
+296 ;;=PROSTHETIC ANEURYSM REPAIR^19^19
+297 ;;^UTILITY(U,$J,358.4,147,0)
+298 ;;=DEVICE PROGRAMMING^4^19
+299 ;;^UTILITY(U,$J,358.4,148,0)
+300 ;;=ECHO^5^19
+301 ;;^UTILITY(U,$J,358.4,149,0)
+302 ;;=EKG^6^19
+303 ;;^UTILITY(U,$J,358.4,150,0)
+304 ;;=MEDICATION ADMINISTRATION^9^19
+305 ;;^UTILITY(U,$J,358.4,151,0)
+306 ;;=MEDICATIONS^10^19
+307 ;;^UTILITY(U,$J,358.4,152,0)
+308 ;;=OTHER CARDIAC^12^19
+309 ;;^UTILITY(U,$J,358.4,153,0)
+310 ;;=STRESS TESTS^20^19
+311 ;;^UTILITY(U,$J,358.4,154,0)
+312 ;;=PREVENTIVE COUNSELING^17^19
+313 ;;^UTILITY(U,$J,358.4,155,0)
+314 ;;=MODERATE SEDATION (MS)^11^19
+315 ;;^UTILITY(U,$J,358.4,156,0)
+316 ;;=VENTRICULAR ASSIST DEVICE INSERTION^22^19
+317 ;;^UTILITY(U,$J,358.4,157,0)
+318 ;;=CARDIOVERSION^1^19
+319 ;;^UTILITY(U,$J,358.4,158,0)
+320 ;;=PROLONGED SERVICES^18^19
+321 ;;^UTILITY(U,$J,358.4,159,0)
+322 ;;=COUNSELING/EDUCATION^5^20
+323 ;;^UTILITY(U,$J,358.4,160,0)
+324 ;;=PSYCHIATRIC THERAPY^10^20
+325 ;;^UTILITY(U,$J,358.4,161,0)
+326 ;;=BIOFEEDBACK THERAPY^2^20
+327 ;;^UTILITY(U,$J,358.4,162,0)
+328 ;;=BIOPSYCHOSOCIAL ASSESS/INTERVENTION^3^20
+329 ;;^UTILITY(U,$J,358.4,163,0)
+330 ;;=PHYSICAL THERAPY^9^20
+331 ;;^UTILITY(U,$J,358.4,164,0)
+332 ;;=OTHER THERAPEUTIC TECHNIQUES^8^20
+333 ;;^UTILITY(U,$J,358.4,165,0)
+334 ;;=ACUPUNTURE^1^20
+335 ;;^UTILITY(U,$J,358.4,166,0)
+336 ;;=OSTEOPATHIC MANIPULATION^7^20
+337 ;;^UTILITY(U,$J,358.4,167,0)
+338 ;;=CHIROPRACTIC MANIPULATION^4^20
+339 ;;^UTILITY(U,$J,358.4,168,0)
+340 ;;=SELF-MANAGEMENT TRAINING^11^20
+341 ;;^UTILITY(U,$J,358.4,169,0)
+342 ;;=NUTRITION APPROACHES^6^20
+343 ;;^UTILITY(U,$J,358.4,170,0)
+344 ;;=VA WHOLE HEALTH PARTNER SVCS^12^20
+345 ;;^UTILITY(U,$J,358.4,171,0)
+346 ;;=COUNSELING^2^21
+347 ;;^UTILITY(U,$J,358.4,172,0)
+348 ;;=HISTORY OF ILLNESS^7^21
+349 ;;^UTILITY(U,$J,358.4,173,0)
+350 ;;=OTHER^19^21
+351 ;;^UTILITY(U,$J,358.4,174,0)
+352 ;;=SCREENING^14^21
+353 ;;^UTILITY(U,$J,358.4,175,0)
+354 ;;=CARDIOVASCULAR DISORDER^1^21
+355 ;;^UTILITY(U,$J,358.4,176,0)
+356 ;;=DIABETIC MANAGEMENT^3^21
+357 ;;^UTILITY(U,$J,358.4,177,0)
+358 ;;=ENDOCRINE DISORDER^4^21
+359 ;;^UTILITY(U,$J,358.4,178,0)
+360 ;;=HEARING DISORDER^6^21
+361 ;;^UTILITY(U,$J,358.4,179,0)
+362 ;;=GASTROINTESTINAL DISORDER^5^21
+363 ;;^UTILITY(U,$J,358.4,180,0)
+364 ;;=INJURIES^8^21
+365 ;;^UTILITY(U,$J,358.4,181,0)
+366 ;;=NEOPLASM^11^21
+367 ;;^UTILITY(U,$J,358.4,182,0)
+368 ;;=RESPIRATORY DISORDER^13^21
+369 ;;^UTILITY(U,$J,358.4,183,0)
+370 ;;=SIGNS AND SYMPTOMS^15^21
+371 ;;^UTILITY(U,$J,358.4,184,0)
+372 ;;=SUBSTANCE DISORDERS^16^21
+373 ;;^UTILITY(U,$J,358.4,185,0)
+374 ;;=WEIGHT MANAGEMENT^18^21
+375 ;;^UTILITY(U,$J,358.4,186,0)
+376 ;;=MOOD DISORDER^9^21
+377 ;;^UTILITY(U,$J,358.4,187,0)
+378 ;;=MUSCULOSKELETAL DISORDER^10^21
+379 ;;^UTILITY(U,$J,358.4,188,0)
+380 ;;=NEUROLOGICAL^12^21
+381 ;;^UTILITY(U,$J,358.4,189,0)
+382 ;;=SUICIDE IDEATIONS/ATTEMPTS^17^21
+383 ;;^UTILITY(U,$J,358.4,190,0)
+384 ;;=ESTABLISHED PATIENT^1^22
+385 ;;^UTILITY(U,$J,358.4,191,0)
+386 ;;=NEW PATIENT^2^22
+387 ;;^UTILITY(U,$J,358.4,192,0)
+388 ;;=NEW PATIENT^2^24
+389 ;;^UTILITY(U,$J,358.4,193,0)
+390 ;;=ESTABLISHED PATIENT^1^24
+391 ;;^UTILITY(U,$J,358.4,194,0)
+392 ;;=CONSULTATIONS^3^24
+393 ;;^UTILITY(U,$J,358.4,195,0)
+394 ;;=POST-OP FOLLOW-UP^4^24
+395 ;;^UTILITY(U,$J,358.4,196,0)
+396 ;;=DEBRIDEMENT^2^25
+397 ;;^UTILITY(U,$J,358.4,197,0)
+398 ;;=DESTR-BENIGN/PREMALIGNANT^6^25
+399 ;;^UTILITY(U,$J,358.4,198,0)
+400 ;;=DEST MAL LESION-TRUNK,ARMS,LEGS^5^25
+401 ;;^UTILITY(U,$J,358.4,199,0)
+402 ;;=EXC-BEN LESION-TRUNK,ARM,LEG^10^25
+403 ;;^UTILITY(U,$J,358.4,200,0)
+404 ;;=EXC-MAL LESION-TRUNK,ARM,LEG^13^25
+405 ;;^UTILITY(U,$J,358.4,201,0)
+406 ;;=INCISION & DRAINAGE^15^25
+407 ;;^UTILITY(U,$J,358.4,202,0)
+408 ;;=MISCELLANEOUS^18^25
+409 ;;^UTILITY(U,$J,358.4,203,0)
+410 ;;=NAILS^20^25
+411 ;;^UTILITY(U,$J,358.4,204,0)
+412 ;;=SHAVING-EPIDERMAL-TRUNK,ARM,LEG^34^25
+413 ;;^UTILITY(U,$J,358.4,205,0)
+414 ;;=REPAIR-SIMPLE-SCALP,NK,TRUNK^31^25
+415 ;;^UTILITY(U,$J,358.4,206,0)
+416 ;;=REPAIR-INTERM-SCALP,TRUNK^29^25
+417 ;;^UTILITY(U,$J,358.4,207,0)
+418 ;;=DEST MAL LES-SCALP,NK,HAND,FEET,GENITALS^4^25
+419 ;;^UTILITY(U,$J,358.4,208,0)
+420 ;;=DEST MAL LESION-FACE,MUCOUS^3^25
+421 ;;^UTILITY(U,$J,358.4,209,0)
+422 ;;=EXC-BEN LESION-SCALP,HANDS,FT,GENITALS^9^25
+423 ;;^UTILITY(U,$J,358.4,210,0)
+424 ;;=EXC-BEN LESION-FACE,MUCOUS^8^25
+425 ;;^UTILITY(U,$J,358.4,211,0)
+426 ;;=EXC-MAL LESION-SCALP,NK,HAND,FT,GENITALS^12^25
+427 ;;^UTILITY(U,$J,358.4,212,0)
+428 ;;=EXC-MAL LESION-FACE,MUCOUS^11^25
+429 ;;^UTILITY(U,$J,358.4,213,0)
+430 ;;=SHAVING-EPIDERM-SCALP,NK,HAND,FT,GENITAL^33^25
+431 ;;^UTILITY(U,$J,358.4,214,0)
+432 ;;=SHAVING-EPIDERM-FACE,MUCOUS^32^25
+433 ;;^UTILITY(U,$J,358.4,215,0)
+434 ;;=REPAIR-SIMPLE-FACE,MUCOUS^30^25
+435 ;;^UTILITY(U,$J,358.4,216,0)
+436 ;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^28^25
+437 ;;^UTILITY(U,$J,358.4,217,0)
+438 ;;=REPAIR-INTERM-FACE,MUCOUS^27^25
+439 ;;^UTILITY(U,$J,358.4,218,0)
+440 ;;=WOUND HEALING^42^25
+441 ;;^UTILITY(U,$J,358.4,219,0)
+442 ;;=SKIN TEST^36^25
+443 ;;^UTILITY(U,$J,358.4,220,0)
+444 ;;=MICROBIOLOGY^17^25
+445 ;;^UTILITY(U,$J,358.4,221,0)
+446 ;;=MOHS CHEMOSURGERY^19^25
+447 ;;^UTILITY(U,$J,358.4,222,0)
+448 ;;=INJECTIONS^16^25
+449 ;;^UTILITY(U,$J,358.4,223,0)
+450 ;;=PEEL^21^25
+451 ;;^UTILITY(U,$J,358.4,224,0)
+452 ;;=PHOTOTHERAPY^22^25
+453 ;;^UTILITY(U,$J,358.4,225,0)
+454 ;;=REPAIR-COMPLEX-FACE^23^25
+455 ;;^UTILITY(U,$J,358.4,226,0)
+456 ;;=REPAIR-COMPLEX-NK/HAND/FT^24^25
+457 ;;^UTILITY(U,$J,358.4,227,0)
+458 ;;=REPAIR-COMPLEX-TRUNK^26^25
+459 ;;^UTILITY(U,$J,358.4,228,0)
+460 ;;=TISSUE REARRANGMNT-FACE/NECK/HAND/FOOT^39^25
+461 ;;^UTILITY(U,$J,358.4,229,0)
+462 ;;=TISSUE REARRANGMNT-SCALP/ARMS/LEGS^40^25
+463 ;;^UTILITY(U,$J,358.4,230,0)
+464 ;;=TISSUE REARRANGMNT-TRUNK^41^25
+465 ;;^UTILITY(U,$J,358.4,231,0)
+466 ;;=REPAIR-COMPLEX-SCALP^25^25
+467 ;;^UTILITY(U,$J,358.4,232,0)
+468 ;;=TISSUE REARRANGMNT-EYELID/NOSE/EAR/LIP^38^25
+469 ;;^UTILITY(U,$J,358.4,233,0)
+470 ;;=BIOPSY^1^25
+471 ;;^UTILITY(U,$J,358.4,234,0)
+472 ;;=TISSUE REARRANGEMENT-ANY AREA^37^25
+473 ;;^UTILITY(U,$J,358.4,235,0)
+474 ;;=SKIN GRAFT/AUTOGRAFT^35^25
+475 ;;^UTILITY(U,$J,358.4,236,0)
+476 ;;=DESTR-CUT VASC PROLIFERATION^7^25
+477 ;;^UTILITY(U,$J,358.4,237,0)
+478 ;;=FINE NEEDLE ASPIRATION BIOPSY^14^25
+479 ;;^UTILITY(U,$J,358.4,238,0)
+480 ;;=A DIAGNOSES^2^26
+481 ;;^UTILITY(U,$J,358.4,239,0)
+482 ;;=D DIAGNOSES^5^26
+483 ;;^UTILITY(U,$J,358.4,240,0)
+484 ;;=E DIAGNOSES^6^26
+485 ;;^UTILITY(U,$J,358.4,241,0)
+486 ;;=F DIAGNOSES^7^26
+487 ;;^UTILITY(U,$J,358.4,242,0)
+488 ;;=I DIAGNOSES^10^26
+489 ;;^UTILITY(U,$J,358.4,243,0)
+490 ;;=K DIAGNOSES^11^26
+491 ;;^UTILITY(U,$J,358.4,244,0)
+492 ;;=M DIAGNOSES^13^26
+493 ;;^UTILITY(U,$J,358.4,245,0)
+494 ;;=N DIAGNOSES^14^26
+495 ;;^UTILITY(U,$J,358.4,246,0)
+496 ;;=P DIAGNOSES^16^26
+497 ;;^UTILITY(U,$J,358.4,247,0)
+498 ;;=R DIAGNOSES^17^26
+499 ;;^UTILITY(U,$J,358.4,248,0)
+500 ;;=S DIAGNOSES^18^26
+501 ;;^UTILITY(U,$J,358.4,249,0)
+502 ;;=T DIAGNOSES^20^26
+503 ;;^UTILITY(U,$J,358.4,250,0)
+504 ;;=V DIAGNOSES^22^26
+505 ;;^UTILITY(U,$J,358.4,251,0)
+506 ;;=X DIAGNOSES^24^26
+507 ;;^UTILITY(U,$J,358.4,252,0)
+508 ;;=C DIAGNOSES^4^26
+509 ;;^UTILITY(U,$J,358.4,253,0)
+510 ;;=W DIAGNOSES^23^26
+511 ;;^UTILITY(U,$J,358.4,254,0)
+512 ;;=B DIAGNOSES^3^26
+513 ;;^UTILITY(U,$J,358.4,255,0)
+514 ;;=G DIAGNOSES^8^26
+515 ;;^UTILITY(U,$J,358.4,256,0)
+516 ;;=H DIAGNOSES^8^26
+517 ;;^UTILITY(U,$J,358.4,257,0)
+518 ;;=L DIAGNOSES^12^26
+519 ;;^UTILITY(U,$J,358.4,258,0)
+520 ;;=O DIAGNOSES^15^26
+521 ;;^UTILITY(U,$J,358.4,259,0)
+522 ;;=U DIAGNOSES^21^26
+523 ;;^UTILITY(U,$J,358.4,260,0)
+524 ;;=Z DIAGNOSES^25^26
+525 ;;^UTILITY(U,$J,358.4,261,0)
+526 ;;=SUICIDE IDEATIONS/ATTEMPTS^19^26
+527 ;;^UTILITY(U,$J,358.4,262,0)
+528 ;;=MOST COMMON DX^1^26
+529 ;;^UTILITY(U,$J,358.4,263,0)
+530 ;;=NEW PATIENT^3^27
+531 ;;^UTILITY(U,$J,358.4,264,0)
+532 ;;=ESTABLISHED PATIENT^1^27
+533 ;;^UTILITY(U,$J,358.4,265,0)
+534 ;;=CONSULTATIONS^2^27
+535 ;;^UTILITY(U,$J,358.4,266,0)
+536 ;;=PREVENTIVE MEDICINE-EST PT^4^27
+537 ;;^UTILITY(U,$J,358.4,267,0)
+538 ;;=PREVENTIVE MEDICINE-NEW PT^5^27
+539 ;;^UTILITY(U,$J,358.4,268,0)
+540 ;;=RISK FACTOR REDUCTION-GRP^6^27
+541 ;;^UTILITY(U,$J,358.4,269,0)
+542 ;;=RISK FACTOR REDUCTION-IND^7^27
+543 ;;^UTILITY(U,$J,358.4,270,0)
+544 ;;=OTHER^3^28
+545 ;;^UTILITY(U,$J,358.4,271,0)
+546 ;;=EDUCATION/TRAINING^1^28
+547 ;;^UTILITY(U,$J,358.4,272,0)
+548 ;;=MEDICAL NUTRITION THERAPY^2^28
+549 ;;^UTILITY(U,$J,358.4,273,0)
+550 ;;=WOUND TREATMENT^5^28
+551 ;;^UTILITY(U,$J,358.4,274,0)
+552 ;;=PROLONGED SERVICES^4^28
+553 ;;^UTILITY(U,$J,358.4,275,0)
+554 ;;=DIABETES^1^29
+555 ;;^UTILITY(U,$J,358.4,276,0)
+556 ;;=SUICIDE IDEATIONS/ATTEMPTS^2^29
+557 ;;^UTILITY(U,$J,358.4,277,0)
+558 ;;=NEW PATIENT^2^30
+559 ;;^UTILITY(U,$J,358.4,278,0)
+560 ;;=ESTABLISHED PATIENT^1^30
+561 ;;^UTILITY(U,$J,358.4,279,0)
+562 ;;=CONSULTATIONS^3^30
+563 ;;^UTILITY(U,$J,358.4,280,0)
+564 ;;=ENDOCRINE DX^1^31
+565 ;;^UTILITY(U,$J,358.4,281,0)
+566 ;;=SUICIDE IDEATIONS/ATTEMPTS^2^31
+567 ;;^UTILITY(U,$J,358.4,282,0)
+568 ;;=BIOPSIES^1^32
+569 ;;^UTILITY(U,$J,358.4,283,0)
+570 ;;=INJECTIONS & INFUSIONS^2^32
+571 ;;^UTILITY(U,$J,358.4,284,0)
+572 ;;=OTHER^4^32
+573 ;;^UTILITY(U,$J,358.4,285,0)
+574 ;;=PROLONGED CLINICAL STAFF SERVICES^5^32
+575 ;;^UTILITY(U,$J,358.4,286,0)
+576 ;;=LAB TESTS^3^32
+577 ;;^UTILITY(U,$J,358.4,287,0)
+578 ;;=NEW PATIENT^3^33
+579 ;;^UTILITY(U,$J,358.4,288,0)
+580 ;;=ESTABLISHED PATIENT^2^33
+581 ;;^UTILITY(U,$J,358.4,289,0)
+582 ;;=CONSULTS - OUTPT^4^33
+583 ;;^UTILITY(U,$J,358.4,290,0)
+584 ;;=EYE CODES^1^33
+585 ;;^UTILITY(U,$J,358.4,291,0)
+586 ;;=CONSULTS - INPT^5^33
+587 ;;^UTILITY(U,$J,358.4,292,0)
+588 ;;=HOSPITAL CARE - INITIAL^6^33
+589 ;;^UTILITY(U,$J,358.4,293,0)
+590 ;;=HOSPITAL CARE - SUBSEQUENT^7^33
+591 ;;^UTILITY(U,$J,358.4,294,0)
+592 ;;=HOSPITAL CARE - DISCHARGE^8^33
+593 ;;^UTILITY(U,$J,358.4,295,0)
+594 ;;=OBSERVATION CARE - INITIAL^9^33
+595 ;;^UTILITY(U,$J,358.4,296,0)
+596 ;;=OBSERVATION CARE - SUBSEQUENT^10^33
+597 ;;^UTILITY(U,$J,358.4,297,0)
+598 ;;=OBSERVATION CARE - DISCHARGE^11^33
+599 ;;^UTILITY(U,$J,358.4,298,0)
+600 ;;=INPT or OBS - ADMIT & DISCHARGE SAME DAY^12^33
+601 ;;^UTILITY(U,$J,358.4,299,0)
+602 ;;=EEF Version 2022 April^13^33
+603 ;;^UTILITY(U,$J,358.4,300,0)
+604 ;;=PROC - LID / LACRIMAL^7^34
+605 ;;^UTILITY(U,$J,358.4,301,0)
+606 ;;=PROC - LASER / CRYO^10^34
+607 ;;^UTILITY(U,$J,358.4,302,0)
+608 ;;=PROC - CORNEA / CONJ^6^34
+609 ;;^UTILITY(U,$J,358.4,303,0)
+610 ;;=MEDICATIONS^12^34
+611 ;;^UTILITY(U,$J,358.4,304,0)
+612 ;;=PROC - INJECTIONS / ALL^9^34
+613 ;;^UTILITY(U,$J,358.4,305,0)
+614 ;;=IMAGE / PHOTOS^2^34
+615 ;;^UTILITY(U,$J,358.4,306,0)
+616 ;;=REFRACT / GLASSES / CL^1^34
+617 ;;^UTILITY(U,$J,358.4,307,0)
+618 ;;=TEST - CATARACT / CORNEA^4^34
+619 ;;^UTILITY(U,$J,358.4,308,0)
+620 ;;=TEST - GLAUCOMA^3^34
+621 ;;^UTILITY(U,$J,358.4,309,0)
+622 ;;=TEST - OTHER^5^34
+623 ;;^UTILITY(U,$J,358.4,310,0)
+624 ;;=EDUCATION / COUNSELING^13^34
+625 ;;^UTILITY(U,$J,358.4,311,0)
+626 ;;=EYE SURGERY CODES^11^34
+627 ;;^UTILITY(U,$J,358.4,312,0)
+628 ;;=PROC - INJECTIONS / VEGF^8^34
+629 ;;^UTILITY(U,$J,358.4,313,0)
+630 ;;=TEST - ERG / VEP^14^34
+631 ;;^UTILITY(U,$J,358.4,314,0)
+632 ;;=LOW VISION / BLINDNESS^21^35
+633 ;;^UTILITY(U,$J,358.4,315,0)
+634 ;;=RETINA - VASCULAR^12^35
+635 ;;^UTILITY(U,$J,358.4,316,0)
+636 ;;=EYELIDS / LASHES^2^35
+637 ;;^UTILITY(U,$J,358.4,317,0)
+638 ;;=NEURO / STRABISMUS^18^35
+639 ;;^UTILITY(U,$J,358.4,318,0)
+640 ;;=ORBIT - PLASTICS^20^35
+641 ;;^UTILITY(U,$J,358.4,319,0)
+642 ;;=VITREOUS^17^35
+643 ;;^UTILITY(U,$J,358.4,320,0)
+644 ;;=ORBIT - TRAUMA^19^35
+645 ;;^UTILITY(U,$J,358.4,321,0)
+646 ;;=LACRIMAL / NLD / NEOPLASMS^3^35
+647 ;;^UTILITY(U,$J,358.4,322,0)
+648 ;;=MOST FREQUENT^1^35
